Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: REGENERON PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2017-09-30 to 2027-09-29
Current total value of award: $693056926.67
Description: EBOLA THERAPEUTICS